Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

17. Juni 2026 07:00 ET | Quelle: Exousia Pro, Inc.

NexTel Medical Outlines its Revenue Model Using the Innovation of Tomorrow: Synergy of Advanced Medical Technologies and Massive Sales Infrastructure Primed to Drive Exponential Growth

OTCID:MAJI announced a strategic pivot, evolutionary restructuring, and operational alignment designed to transition the company
11. Juni 2026 11:57 ET | Quelle: Human Continuum Inc.

Human Continuum Closes Over $5 Million in Seed Round Funding to Support the Development of its Integrated Exosome-Based Therapeutic Longevity Platform

Jupiter, F.L., June 11, 2026 (GLOBE NEWSWIRE) -- Human Continuum Inc. (“HC” or “the Company”), a developer of platelet-derived and plant-based exosome therapeutics and diagnostics, today announced...
09. Juni 2026 07:00 ET | Quelle: Exousia Pro, Inc.

NexTel Medical Corp. Announces Groundbreaking, First-of-Its-Kind Exosome Characterization Study with Penn State University

MAJI announced a historic, first-of-its-kind analytical study in collaboration with Pennsylvania State University and esteemed Scientific Advisory Board.
28. Mai 2026 07:54 ET | Quelle: Research and Markets

Tumor Exosome Profiling Global Market Analysis Report 2026: $2.49 Bn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

Dublin, May 28, 2026 (GLOBE NEWSWIRE) -- The "Tumor Exosome Profiling Global Market Report 2026" has been added to ResearchAndMarkets.com's offering. The tumor exosome profiling market has...
13. Mai 2026 11:00 ET | Quelle: BioRestorative Therapies, Inc

BioRestorative Therapies Presents New Preclinical Data at ISCT 2026 Highlighting Source-Specific Exosome Functionality and Commercial Applications in BioCosmeceuticals

Data demonstrate distinct functional signatures across MSC-derived extracellular vesicles supporting targeted regenerative and aesthetic applications MELVILLE, N.Y., May 13, 2026 (GLOBE NEWSWIRE)...
30. April 2026 11:40 ET | Quelle: Research and Markets

Exosome Therapy Market Size and Industry Dynamics 2026-2035 - Standardization Challenges Loom Over Booming $58 Billion Exosome Therapy Industry

Dublin, April 30, 2026 (GLOBE NEWSWIRE) -- The "Exosome Therapy Market by Exosome Source Type; Treatment Setting; Therapy Modality; Therapeutic Use Case; Administration Approach; Regulatory...
20. März 2026 06:45 ET | Quelle: Research and Markets

U.S. Exosomes Market to Skyrocket During 2026-2033, Reaching $716.8 Million - Analysis of Lucrative Business Opportunities and Key Players; Danaher, Thermo Fisher Scientific, Hologic, Fujifilm, Lonza and More

Dublin, March 20, 2026 (GLOBE NEWSWIRE) -- The "U.S. Exosomes Market Size, Share & Trends Analysis Report by Product & Service, Application, Workflow, End Use, and Segment Forecasts,...
13. März 2026 08:47 ET | Quelle: Research and Markets

Exosome Research Market Analysis, Opportunity Forecasts Report 2026-2035

Dublin, March 13, 2026 (GLOBE NEWSWIRE) -- The "Exosome Research Market Analysis, Opportunity Forecasted For 2026-2035" has been added to ResearchAndMarkets.com's offering. The exosome...
05. März 2026 08:00 ET | Quelle: BioRestorative Therapies, Inc

BioRestorative Therapies, Inc. to Participate in the Be+Well Beauty and Wellness Show in New York City, March 8-10, 2026

Company to engage industry partners and distribution channels as part of expanding BioCosmeceutical commercialization strategy MELVILLE, N.Y., March 05, 2026 (GLOBE NEWSWIRE) -- BioRestorative...
24. Februar 2026 09:00 ET | Quelle: Human Continuum Inc.

Human Continuum Appoints Dr. Michael Milligan, MD, MBA, as its Chief Medical Officer to Oversee Innovative Applications for Next-Generation Extracellular Vesicle Therapeutics

New York, N.Y., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Human Continuum Inc. (“HC” or “the Company”), a developer of platelet-derived and plant-based exosome therapeutics and diagnostics, today announced...

Nächste Seite